Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,444.25
(
0.58%
)
US TECH 100
28,732.00
(
1.56%
)
Dow Jones
49,693.20
(
-0.14%
)
Brent Oil
103.69
(
-1.96%
)
Bitcoin
79,316.74
(
-1.46%
)
News Focus
News Focus
Post# of 826012
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

ATLnsider

Send PM Follow Ignore
Followers 175
Posts 3509
Boards Moderated 1
Alias Born 11/03/2014

ATLnsider

Re: sharpie510 post# 408911

Wednesday, 10/13/2021 5:40:14 PM

Wednesday, October 13, 2021 5:40:14 PM

Post# of 826012
My guess is: if Dr. Linda Liau and NWBio are given a DCVax-L Phase III clinical trial publication date by the selected journal (Lancet, JAMA, NEJM, or etc.), that is before SNO 2021 starts (November 18, 2021), then Dr. Linda Liau will be added to the list of speakers at SNO 2021.

If that happens, then I believe that we will get top line data (TLD), and the DCVax-L journal article before 11/18/2021.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News